ADVFN ADVFN

Hot Features

Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Grace Therapeutics Inc

Grace Therapeutics Inc (GRCE)

2.20
-0.10
(-4.35%)
終了 6月14日 5:00AM
2.24
0.04
(1.82%)
取引時間後: 7:24AM

Grace Therapeutics Inc (GRCE) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

主要統計と詳細

通貨
2.24
( -2.61% )
買値
1.70
売値
2.76
出来高
412,692
2.16 日の範囲 2.34
1.79 52 週間の範囲 5.18
時価総額
前日終値
2.30
始値
2.31
最終取引時間
財務取引量
US$ 921,977
VWAP
2.2341
平均取引量 (3 か月)
US$ 771,913
発行済株式数
15,474,026
配当利回り
PER
-6.05
1 株当たり利益 (EPS)
-0.38
歳入
-
純利益
-5.98M

Grace Therapeutics Inc について

Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company’s lead product candidate is the GTX-104, an intravenous infusion to treat subarachnoid hemorrhage. It also develops GTX-102, an oral mucosal spray ... Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company’s lead product candidate is the GTX-104, an intravenous infusion to treat subarachnoid hemorrhage. It also develops GTX-102, an oral mucosal spray of betamethasone to improve neurological symptoms of Ataxia-Telangiectasia (A-T) and GTX-101, a topical bioadhesive film-forming polymer for the treatment of pain associated with postherpetic neuralgia (PHN). The company was formerly known as Acasti Pharma Inc. and changed its name to Grace Therapeutics, Inc. in October 2024. Grace Therapeutics, Inc. was incorporated in 2002 and is headquartered in Princeton, New Jersey. 詳細を表示

セクター
Healthcare
業界
Biotechnology & Life Sciences
ウェブサイト
本社
Princeton, United States
設立
2026
Grace Therapeutics Inc is listed in the Healthcare sector of the ナスダック市場 with ticker GRCE. The last closing price for Grace Therapeutics was US$2.30. Over the last year, Grace Therapeutics shares have traded in a share price range of US$ 1.79 to US$ 5.18.

Grace Therapeutics currently has 15,474,026 shares in issue. The market capitalisation of Grace Therapeutics is US$34.66 million. Grace Therapeutics has a price to earnings ratio (PE ratio) of -6.05.

GRCE 最新ニュース

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.14-5.882352941182.382.522.2151903442.30966041CS
40.073.225806451612.172.712.082752722.3559842CS
12-2.12-48.6238532114.365.181.797653433.18223427CS
26-1.06-32.12121212123.35.181.794566273.34488211CS
52-0.63-21.95121951222.875.181.792617013.31503068CS
156-0.8-26.31578947373.045.181.751823093.32208622CS
260-0.8-26.31578947373.045.181.751823093.32208622CS

GRCE - Frequently Asked Questions (FAQ)

What is the current Grace Therapeutics Inc share price?
The current share price of Grace Therapeutics Inc is US$ 2.24
How many Grace Therapeutics Inc shares are in issue?
Grace Therapeutics Inc has 15,474,026 shares in issue
What is the market cap of Grace Therapeutics Inc?
The market capitalisation of Grace Therapeutics Inc is USD 34.66M
What is the 1 year trading range for Grace Therapeutics Inc share price?
Grace Therapeutics Inc has traded in the range of US$ 1.79 to US$ 5.18 during the past year
What is the PE ratio of Grace Therapeutics Inc?
The price to earnings ratio of Grace Therapeutics Inc is -6.05
What is the registered address of Grace Therapeutics Inc?
The registered address for Grace Therapeutics Inc is 103 Carnegie Center, Princeton, New Jersey, 08540
What is the Grace Therapeutics Inc website address?
The website address for Grace Therapeutics Inc is www.gracetx.com
Which industry sector does Grace Therapeutics Inc operate in?
Grace Therapeutics Inc operates in the Biotechnology & Life Sciences sector

GRCE 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード

最近閲覧した銘柄

Delayed Upgrade Clock